Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Monami

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Endocrinological Investigation|January 20, 2006
Seizures as the only clinical manifestation of reactive hypoglycemia: a case reportM Monami, E Mannucci, A Breschi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 12, 2009
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trialsM Monami, I Iacomelli, N Marchionni, et al.
Diabetes, Obesity & Metabolism|August 29, 2012
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trialsM Monami, B Ahrén, I Dicembrini, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patientsM Monami, N Marchionni, G Masotti, et al.
Journal of Endocrinological Investigation|October 10, 2007
Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: what makes the difference?M Monami, N Marchionni, G Masotti, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 21, 2009
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysisM Monami, C Lamanna, N Marchionni, et al.
Diabetes, Obesity & Metabolism|July 9, 2013
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trialsM Monami, I Dicembrini, C Nardini, et al.
Journal of Endocrinological Investigation|February 15, 2019
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trialsI Dicembrini, S Giannini, B Ragghianti, et al.
Acta Diabetologica|August 14, 2020
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trialsI Dicembrini, C Cosentino, M Monami, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 12, 2009
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trialsE Mannucci, M Monami, C Lamanna, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Endocrinological Investigation|January 20, 2006
Seizures as the only clinical manifestation of reactive hypoglycemia: a case reportM Monami, E Mannucci, A Breschi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 12, 2009
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trialsM Monami, I Iacomelli, N Marchionni, et al.
Diabetes, Obesity & Metabolism|August 29, 2012
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trialsM Monami, B Ahrén, I Dicembrini, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patientsM Monami, N Marchionni, G Masotti, et al.
Journal of Endocrinological Investigation|October 10, 2007
Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: what makes the difference?M Monami, N Marchionni, G Masotti, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 21, 2009
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysisM Monami, C Lamanna, N Marchionni, et al.
Diabetes, Obesity & Metabolism|July 9, 2013
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trialsM Monami, I Dicembrini, C Nardini, et al.
Journal of Endocrinological Investigation|February 15, 2019
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trialsI Dicembrini, S Giannini, B Ragghianti, et al.
Acta Diabetologica|August 14, 2020
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trialsI Dicembrini, C Cosentino, M Monami, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 12, 2009
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trialsE Mannucci, M Monami, C Lamanna, et al.
Pageof 6